Combination of lorvotuzumab mertansine, dexamethasone and lenalidomide is safe in multiple myeloma June 27, 2011
Interim first-in-human data support safety/activity of INCB-028060 in advanced solid tumors June 27, 2011
Phase II trial assesses second-line danusertib in metastatic castration-resistant prostate cancer June 27, 2011
MAb hu3S193 stabilizes disease in phase II trial in ovarian, peritoneal and fallopian tube cancer June 22, 2011
RSS